Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional) (PAR-24-273)
Sponsor: National Institutes of Health
Due Date: Multiple due dates; see announcement.
306 RESULTS
You searched specialized-centers-research-excellence-score-sex-differences-u54-clinical-trial-optional-rfa
To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.
Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.
Sponsor: National Institutes of Health
Due Date: Multiple due dates; see announcement.
Sponsor: National Institute on Aging
Award: For the R61 exploratory phase, the combined budget for direct costs for the two-year project period may not exceed $500,000, with no more than $250,000 requested in any single year. For the three-year R33 implementation phase, applicants' combined budget for direct costs may not exceed $1,500,000, with no more than $500,000 requested in any single year.
Due Date: November 07, 2024.
Sponsor: National Institute on Aging
Award: Direct costs up to $350,000 per year may be requested. The maximum project period is 5 years.
Due Date: October 10, 2024.
Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging
Award: One-year administrative supplement to provide support for currently active NINDS Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD) awards to add/include APOE genotype and fluid-based AD/ADRD biomarkers to ongoing AD/ADRD human subjects research studies. Individual requests can be no more than $150,000 in direct costs.
Due Date: November 11, 2024.
Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging
Due Date: October 04, 2024.
Sponsor: National Institute on Aging
Due Date: Estimated Publication Date of Notice of Funding Opportunity: November 01, 2024. First Estimated Application Due Date: February 12, 2025.
Sponsor: National Institute of Neurological Disorders and Stroke
Due Date: Estimated Publication Date of Notice of Funding Opportunity: September 13, 2024. First Estimated Application Due Date: June 02, 2025.
Sponsor: National Institute on Aging
Due Date: Letter of Intent due October 7, 2024. Application due November 07, 2024.
Sponsor: U.S. Food and Drug Administration
Due Date: 2024 dates: LOI due September 22, 2024; application due October 22, 2024. 2025 dates: LOI due September 21, 2025; application due October 21, 2025.
Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging
Award: Application budgets are limited to no more than $1,000,000 in direct costs per year. The maximum project period is five years.
Due Date: November 19, 2024.
Sponsor: National Institutes of Health
Due Date: Estimated Publication Date of Notice of Funding Opportunity: October 01, 2024. First Estimated Application Due Date: January 27, 2025.
Sponsor: National Institutes of Health
Due Date: Estimated Publication Date of Notice of Funding Opportunity: October 01, 2024. First Estimated Application Due Date: January 27, 2025.
Sponsor: The McKnight Endowment Fund for Neuroscience
Award: Applicants for the McKnight Scholar Awards must be independent investigators at not-for-profit research institutions in the United States and must hold a faculty position at the rank of Assistant Professor and must have served at that rank for less than five years at the application deadline. Each Scholar will receive $75,000 annually in 2025, 2026, and 2027. Funds may be used in any way that will facilitate development of the Scholar’s research program, but not for indirect costs.
Due Date: January 13, 2025 at 5 PM Central Time.
Sponsor: National Institute of Neurological Disorders and Stroke
Due Date: This Notice informs the extramural community that RFA-NS-24-028 “BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)" will be terminated. The final receipt date, August 21, 2024, has been canceled.
Sponsor: National Institute of Neurological Disorders and Stroke
Due Date: Estimated Publication Date of Notice of Funding Opportunity: October 01, 2024. First Estimated Application Due Date: February 14, 2025.